BBVA USA’s Covetrus, Inc. Common Stock CVET Stock Holding History

BBVA USA’s Portfolio CVET Stock Details CVET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$1K	Hold	42	–	–	﹤0.01%	967
2021 Q2	$1K	Buy	+42	New	+$1.18K	﹤0.01%	1002

Other funds holding CVET

CDR

Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SCHF (GPE) Wilson, Wyoming $781M AUM 24.06% 1-Year Est. Return

FCM

Freshford Capital Management Rye Brook, New York $200M AUM 31.49% 1-Year Est. Return

BBVA USA's CVET Position: Q3 2021 in Review

BBVA USA held its Covetrus, Inc. Common Stock (CVET) position steady in Q3 2021 at 42 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #967.

BBVA USA first reported a position in CVET in Q2 2021 and has held it in 2 quarters since. 260 funds tracked by Wall St. Rank hold CVET as of Q3 2021.

BBVA USA held 42 shares of Covetrus, Inc. Common Stock worth $1K as of Q3 2021.
BBVA USA left its Covetrus, Inc. Common Stock share count unchanged in Q3 2021.
Covetrus, Inc. Common Stock made up ﹤0.01% of BBVA USA's portfolio in Q3 2021, its #967 holding.
BBVA USA first reported a position in Covetrus, Inc. Common Stock in Q2 2021 and has held it in 2 quarters since.
260 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q3 2021.

Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.